| Term | Count | % | | TREATMENT FAILURE | 5915 | 7.04% |
| DRUG INEFFECTIVE | 3208 | 3.82% |
| EYE IRRITATION | 2442 | 2.91% |
| FATIGUE | 2253 | 2.68% |
| INTRAOCULAR PRESSURE INCREASED | 1847 | 2.20% |
| HEADACHE | 1785 | 2.12% |
| EYE PAIN | 1753 | 2.09% |
| DYSPNOEA | 1619 | 1.93% |
| DEATH | 1618 | 1.93% |
| VISION BLURRED | 1602 | 1.91% |
| DIZZINESS | 1595 | 1.90% |
| DIARRHOEA | 1585 | 1.89% |
| OFF LABEL USE | 1543 | 1.84% |
| NAUSEA | 1542 | 1.84% |
| OCULAR HYPERAEMIA | 1452 | 1.73% |
| FALL | 1396 | 1.66% |
| CATARACT | 1370 | 1.63% |
| GLAUCOMA | 1347 | 1.60% |
| PAIN | 1264 | 1.50% |
| ASTHENIA | 1256 | 1.50% |
| HYPERSENSITIVITY | 1164 | 1.39% |
| RASH | 1016 | 1.21% |
| VISUAL IMPAIRMENT | 1012 | 1.20% |
| MALAISE | 998 | 1.19% |
| PNEUMONIA | 973 | 1.16% |
| WEIGHT DECREASED | 945 | 1.12% |
| PRURITUS | 941 | 1.12% |
| CONDITION AGGRAVATED | 929 | 1.11% |
| ARTHRALGIA | 909 | 1.08% |
| PAIN IN EXTREMITY | 909 | 1.08% |
| COUGH | 885 | 1.05% |
| VOMITING | 856 | 1.02% |
| HYPERTENSION | 833 | 0.99% |
| EYE PRURITUS | 795 | 0.95% |
| DRUG HYPERSENSITIVITY | 765 | 0.91% |
| VISUAL ACUITY REDUCED | 728 | 0.87% |
| CONSTIPATION | 724 | 0.86% |
| DRY EYE | 713 | 0.85% |
| PRODUCT DOSE OMISSION ISSUE | 704 | 0.84% |
| INSOMNIA | 686 | 0.82% |
| PYREXIA | 685 | 0.82% |
| CONFUSIONAL STATE | 678 | 0.81% |
| EYE DISORDER | 661 | 0.79% |
| DECREASED APPETITE | 643 | 0.77% |
| DEPRESSION | 643 | 0.77% |
| BACK PAIN | 619 | 0.74% |
| PRODUCT QUALITY ISSUE | 602 | 0.72% |
| CEREBROVASCULAR ACCIDENT | 599 | 0.71% |
| ACUTE KIDNEY INJURY | 590 | 0.70% |
| SOMNOLENCE | 585 | 0.70% |
| URINARY TRACT INFECTION | 581 | 0.69% |
| GAIT DISTURBANCE | 564 | 0.67% |
| ANAEMIA | 554 | 0.66% |
| INCORRECT DOSE ADMINISTERED | 546 | 0.65% |
| BLOOD PRESSURE INCREASED | 535 | 0.64% |
| ANXIETY | 529 | 0.63% |
| FEELING ABNORMAL | 523 | 0.62% |
| HYPOTENSION | 523 | 0.62% |
| CHEST PAIN | 519 | 0.62% |
| LACRIMATION INCREASED | 515 | 0.61% |
| PALPITATIONS | 513 | 0.61% |
| ABDOMINAL DISCOMFORT | 509 | 0.61% |
| ERYTHEMA | 503 | 0.60% |
| COVID-19 | 493 | 0.59% |
| BLINDNESS | 474 | 0.56% |
| MYALGIA | 468 | 0.56% |
| PERIPHERAL SWELLING | 466 | 0.55% |
| ATRIAL FIBRILLATION | 456 | 0.54% |
| PRODUCT USE ISSUE | 454 | 0.54% |
| ARTHRITIS | 452 | 0.54% |
| MUSCLE SPASMS | 448 | 0.53% |
| DRUG INTOLERANCE | 447 | 0.53% |
| NASOPHARYNGITIS | 445 | 0.53% |
| PRODUCT USE IN UNAPPROVED INDICATION | 444 | 0.53% |
| RENAL FAILURE | 436 | 0.52% |
| TREMOR | 435 | 0.52% |
| HAEMOGLOBIN DECREASED | 431 | 0.51% |
| OEDEMA PERIPHERAL | 425 | 0.51% |
| ABDOMINAL PAIN UPPER | 412 | 0.49% |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 407 | 0.48% |
| ABDOMINAL PAIN | 402 | 0.48% |
| ALOPECIA | 397 | 0.47% |
| WEIGHT INCREASED | 394 | 0.47% |
| BRONCHITIS | 391 | 0.47% |
| DEHYDRATION | 390 | 0.46% |
| EYE SWELLING | 388 | 0.46% |
| MUSCULAR WEAKNESS | 386 | 0.46% |
| SYNCOPE | 368 | 0.44% |
| FOREIGN BODY SENSATION IN EYES | 365 | 0.43% |
| MYOCARDIAL INFARCTION | 363 | 0.43% |
| MEMORY IMPAIRMENT | 362 | 0.43% |
| DYSGEUSIA | 356 | 0.42% |
| WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 353 | 0.42% |
| BALANCE DISORDER | 348 | 0.41% |
| BLOOD GLUCOSE INCREASED | 347 | 0.41% |
| VERTIGO | 347 | 0.41% |
| HYPOAESTHESIA | 344 | 0.41% |
| PARAESTHESIA | 343 | 0.41% |
| CARDIAC FAILURE CONGESTIVE | 338 | 0.40% |
| ASTHMA | 336 | 0.40% |
| Total | 84007 | |